Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PD membrane: biological responses to different PD fluids.

Achim Jörres1, Janusz Witowski

  • 1Department of Nephrology and Medical Intensive Care, Charité University Hospital, Campus Virchow-Klinikum, Berlin, Germany.

Contributions to Nephrology
|May 25, 2006
PubMed
Summary

New peritoneal dialysis (PD) solutions free of glucose degradation products improve the longevity of the peritoneum. This enhances patient outcomes in chronic PD therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Problematic relevance of animal studies on peritoneal vascularization to the clinical practice of peritoneal dialysis.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

[34/f with thrombocytopenia and acute renal failure : Preparation for the medical specialist examination: part 19].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2026
Same author

Multidisciplinary guidelines on renal replacement therapy in intensive care medicine.

Critical care (London, England)·2026
Same author

Mesenchymal Stem Cell-Derived Extracellular Vesicles Modulate the Course of Peritoneal Inflammation Through Metabolic and Epigenetic Regulation.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Targeting STING to disrupt macrophage-mediated adhesion in encapsulating peritoneal sclerosis.

Communications biology·2025
Same author

[S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].

Medizinische Klinik, Intensivmedizin und Notfallmedizin·2025

Area of Science:

  • Nephrology
  • Biomaterials Science
  • Clinical Medicine

Background:

  • Chronic peritoneal dialysis (PD) can lead to peritoneal membrane structure and function alterations over time.
  • Infectious complications and dialysis fluid bioincompatibility significantly impact peritoneal membrane longevity.
  • Glucose degradation products in PD solutions are implicated in impaired peritoneal cell function and advanced glycation end product deposition.

Purpose of the Study:

  • To evaluate the impact of novel PD solutions with eliminated glucose degradation products on peritoneal membrane function and patient outcomes.
  • To assess the role of dialysis fluid composition in mitigating long-term PD complications.

Main Methods:

  • Analysis of peritoneal membrane structure and function in chronic PD patients.

Related Experiment Videos

  • Prospective randomized studies comparing novel PD fluids with standard solutions.
  • Measurement of protein glycation and advanced glycation end products deposition.

    • Main Results:

    • Eliminating glucose degradation products from PD solutions improves peritoneal cell function.
    • Reduced protein glycation and deposition of advanced glycation end products observed with novel PD fluids.
    • Prospective studies indicate significant clinical outcome improvements in chronic PD patients using these novel fluids.

    Conclusions:

    • Novel PD solutions designed to eliminate glucose degradation products offer a promising strategy for enhancing peritoneal membrane longevity.
    • Improved peritoneal cell function and reduced glycation contribute to better long-term outcomes in chronic PD.
    • Therapeutic adjustments in dialysis fluid composition are crucial for optimizing chronic PD therapy.